Going from concept to producing over a million clinically validated, FDA-compliant swabs in just a few weeks involved an enormous amount of collaboration and parallel development from domain experts. Hear from Origin CEO, Chris Prucha and Henkel’s 3D Printing Head of Innovation, Ken Kisner on how we worked together along with others to leverage each other’s strengths and get a validated 3D printed medical device to market in record time.
We are very proud to announce the iMakr has officially joined forces with Henkel as a Tier 1 channel partner,... read more
Henkel and Carbon today announced the expansion of their strategic relationship to offer several new resins, which are expected to... read more
Henkel and Keystone Industries (Keystone) today have announced a collaboration between the companies for additive manufacturing solutions in the dental... read more
Our ecosystem partner, Nexa 3D, has announced today that they have signed an exclusive material development agreement with Henkel. This agreement... read more
Open Additive Mass Manufacturing of FDA Compliant NP Swabs. How to bring a new medical device to market in weeks. When... read more
KTM TECHNOLOGIES GmbH is one of the world's most innovative motorcycle and sports car manufacturers. As a company that strives for... read more
Henkel and Stratasys have partnered with one of the world’s leading shoe brands, ECCO, to innovate footwear manufacturing. Using Henkel’s... read more
In this webinar, Additive Manufacturing experts will discuss how Fortify's proprietary technologies, such as Continuous Kinetic Mixing and Fluxprint Magnetic... read more
Until now, the prosumer 3D printing market has been lacking suitable materials that offer speed, precision, and high-grade mechanical properties.... read more
On The Road with LOCTITE features Henkel LOCTITE 3D Printing’s Global Head of Marketing & Strategy, Cindy Deekitwong travelling to... read more
Leave a Reply